Cingulate Inc (CING)

4.36 +0.04 (+0.93%) USD  |  NASDAQ  |  Nov 14, 10:47
More

Cingulate Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for CING.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

United Therapeutics Corp Upgrade
Tonix Pharmaceuticals Holding Corp Upgrade
Geovax Labs Inc --
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade